ISSN 1016-5169 | E-ISSN 1308-4488
pdf
Updated treatment algorithm of pulmonary arterial hypertension [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2014; 42(1): 78-94

Updated treatment algorithm of pulmonary arterial hypertension

Nazzareno Galiè1, Paul A. Corris2, Adaani Frost3, Reda E. Girgis4, John Granton5, Zhi Cheng Jing6, Walter Klepetko7, Michael D. Mcgoon8, Vallerie V. Mclaughlin9, Ioana R. Preston10, Lewis J. Rubin11, Julio Sandoval12, Werner Seeger13, Anne Keogh14
1Bologna University Hospital, Department of Experimental Diagnostic and Specialty Medicine (DIMES), Bologna, Italy
2Institute of Cellular Medicine, Newcastle University vs Newcastle Hospitals NHS Foundation Trust, Newcastle, England
3Baylor College of Medicine, Houston, Texas, USA
4Michigan State University College of Human Medicine, Grand Rapids, Michigan, USA
5University of Toronto, Respiroloj Department, Toronto, Canada
6Fu Wei Peking Union Hospital and the National Center for Cardiovascular Disease Medical College and Chinese Academy of Medical Sciences, Beijing, China
7Medical University of Vienna, Vienna General Hospital, Breast Surgery, Vienna, Austria
8Mayo Clinic, Cardiovascular Diseases, Rochester, Minnesota, USA
9The University of Michigan Cardiovascular Medicine, Ann Arbor, Michigan, USA
10Tufts University School of Medicine, Tufts Mib Center, Pulmonary, Critical Care and Sleep Department, Boston, Massachusetts, USA
11California University, School of Medicine, San Diego, La Jolla, California, USA
12Mexico National Institute of Cardiology, Clinical Research, Mexico City, Mexico
13Universities of Giessen und Marburg Lung Center, the Max Planck Institute for Heart and Lung, Giessen / Bad Nauheim, Germany
14St. Vincent's Hospital, Heart Transplantation Unit, Sydney, Australia

The demands on a pulmonary arterial hypertension (PAH) treatment algorithm are multiple and in some ways conflicting. The treatment algorithm usually includes different types of recommendations with varying degrees of scientific evidence. In addition, the algorithm is required to be comprehensive but not too complex, informative yet simple and straightforward. The type of information in the treatment algorithm are heterogeneous including clinical, hemodynamic, medical, interventional, pharmacological and regulatory recommendations. Stakeholders (or users) including physicians from various specialties and with variable expertise in PAH, nurses, patients and patients’ associations, healthcare providers, regulatory agencies and industry are often interested in the PAH treatment algorithm for different reasons. These are the considerable challenges faced when proposing appropriate updates to the current evidence-based treatment algorithm.The current treatment algorithm may be divided into 3 main areas: 1) general measures, supportive therapy, referral strategy, acute vasoreactivity testing and chronic treatment with calcium channel blockers; 2) initial therapy with approved PAH drugs; and 3) clinical response to the initial therapy, combination therapy, balloon atrial septostomy, and lung transplantation. All three sections will be revisited highlighting information newly available in the past 5 years and proposing updates where appropriate. The European Society of Cardiology grades of recommendation and levels of evidence will be adopted to rank the proposed treatments. (J Am Coll Cardiol 2013;62: D60–72) ©2013 by the American College of Cardiology Foundation.

Keywords: Endothelin receptor antagonists, guanylate cyclase stimulators, hypertension, pulmonary; lung transplantation; phosphodiesterase type-5 inhibitors; prostanoids; pulmonary

How to cite this article
Nazzareno Galiè, Paul A. Corris, Adaani Frost, Reda E. Girgis, John Granton, Zhi Cheng Jing, Walter Klepetko, Michael D. Mcgoon, Vallerie V. Mclaughlin, Ioana R. Preston, Lewis J. Rubin, Julio Sandoval, Werner Seeger, Anne Keogh. Updated treatment algorithm of pulmonary arterial hypertension. Turk Kardiyol Dern Ars. 2014; 42(1): 78-94

Corresponding Author: Nazzareno Galiè, Italy
Manuscript Language: Turkish


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.